LSS 2021 Royalty Rate Survey

2021 Survey Highlights:

• 116 total responses were considered complete for analysis and incorporated into this report. 
• Survey respondents represented 8 of the 31 Licensing Executive Society International (LESI) Societies. 
• Respondents based on number of Deals used in the analysis: 52% Operating Companies, 37% Not-for-Profit Organizations, 2% Government, and 9% Other. Of the Operating Companies, 53% were Pharmaceutical and 27% were Biotech. For Not-for-Profit Organizations, 51% were academic and 35% were Medical Research Institutes. 
• Respondent by Organization Composition: 23% Pharmaceutical Companies (includes Diagnostic and Drug Delivery), 19% Biotech Companies (includes Device), 15% Academic Institutions, 4% Government , and 13% Other.

As a convenient summary (but not a replacement of your agreement to the full Terms of Use, the Terms of Use restrict sharing and public use of the LES Royalty Rate Survey; however, the Terms of Use also authorize sharing and public use according to a set of fees (“Fee Schedule”):

LES individual members: $0

Non-LES members: $795 per individual.

All who download this report must agree to the: